Analystreport

AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) was given a new $13.00 price target on by analysts at Roth Capital. They now have a "buy" rating on the stock.

AcelRx Pharmaceuticals, Inc.  (ACRX) 
Last acelrx pharmaceuticals, inc. earnings: 3/16 07:35 am Check Earnings Report
US:NASDAQ Investor Relations: ir.acelrx.com/investor-relations